Rachelle Jacques

Rachelle Suzanne Jacques is Chairman at Corbus Pharmaceuticals Holdings, Inc. since 2025 and Director at Corbus Pharmaceuticals, Inc. since 2019.
Ms. Jacques serves as Independent Non-Executive Director at uniQure NV since 2021.
Ms. Jacques is a Trustee at Alma College and a Member of the Action for Equality Task Force at the Alliance for Regenerative Medicine.
Former roles include Chief Executive Officer at Enzyvant, Inc. and Enzyvant Therapeutics, Inc. from 2019 to 2022.
Ms. Jacques was Director at Viela Bio, Inc. from 2020 to 2021 and Director at Akari Therapeutics Plc in 2024.
Ms. Jacques was Vice President-Finance & US BioScience Business at Baxter International, Inc. Ms. Jacques was Senior Vice President-Global Complement Franchise at Alexion Pharmaceuticals, Inc. from 2017 to 2019.
Ms. Jacques worked as a Financial Auditor at Ernst & Young LLP and Deloitte & Touche LLP.
Ms. Jacques was Vice President-US Hematology Marketing at Shire Plc from 2016 to 2017 and at Baxalta, Inc. from 2016 to 2017.
Education includes undergraduate studies at Alma College.